Review article · 2026 · Open access
Pharmacogenomic Determinants of Asparaginase‐Induced Hypersensitivity, Pancreatitis, Thrombosis, and Hepatotoxicity in Children: A Systematic Review
Clinical Pharmacology & Therapeutics · Published 13 November 2026 · DOI 10.1002/cpt.70566
In brief
“Pharmacogenomic Determinants of Asparaginase‐Induced Hypersensitivity, Pancreatitis, Thrombosis, and Hepatotoxicity in Children: A Systematic Review” is a 2026 review article by Aniket Chawla and 4 co-authors, published in Clinical Pharmacology & Therapeutics. OpenAlex counts 0 citations as of 18 November 2026. It is open access: the full text is free to read at PubMed Central.
- Citations
- 0
- References
- 69
- Authors
- 5
Abstract
Asparaginase is a common treatment for childhood hematological malignancies, but its use may be limited by toxicities including hypersensitivity, pancreatitis, thrombosis, and hepatotoxicity. Pharmacogenomic testing may identify children who are genetically predisposed to these toxicities, thus enabling personalized treatment. We performed a systematic review to synthesize and critically appraise available evidence for pharmacogenomic associations with asparaginase-induced toxicities in pediatric oncology patients. Literature searches of MEDLINE, Embase, and Web of Science were performed to identify studies investigating genetic associations with asparaginase-induced hypersensitivity, pancreatitis, thrombosis, or hepatotoxicity in children. Data extraction and risk of bias assessment using the Q-GENIE tool were performed independently by two reviewers. Forty studies met inclusion criteria. Evidence was the strongest for hypersensitivity, with consistent replication of associations involving HLA class II alleles, particularly the HLA-DRB1*07:01-HLA-DQA1*02:01-HLA-DQB1*02:02 haplotype, although risk alleles differed by ancestry. For hepatotoxicity, evidence was limited to three studies, but PNPLA3 rs738409 was identified and independently replicated. Associations with pancreatitis and thrombosis were heterogeneous, with numerous candidate loci reported but limited validation across independent cohorts. The overall evidence base was highly heterogeneous, characterized by varying toxicity definitions, inconsistent reporting of statistical power, and limited replication. Current evidence supports HLA class II alleles and PNPLA3 as the most promising pharmacogenomic markers of asparaginase hypersensitivity and hepatotoxicity respectively, but larger, ancestrally diverse studies with standardized toxicity definitions and independent validation are required before routine clinical implementation.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Chawla, A., Halman, A., Carter, S. W. D., Moore, C., & Conyers, R. K. (2026). Pharmacogenomic Determinants of Asparaginase‐Induced Hypersensitivity, Pancreatitis, Thrombosis, and Hepatotoxicity in Children: A Systematic Review. Clinical Pharmacology & Therapeutics. https://doi.org/10.1002/cpt.70566
MLA 9
Chawla, Aniket, et al. “Pharmacogenomic Determinants of Asparaginase‐Induced Hypersensitivity, Pancreatitis, Thrombosis, and Hepatotoxicity in Children: A Systematic Review.” Clinical Pharmacology & Therapeutics, 2026. https://doi.org/10.1002/cpt.70566.
Chicago
Chawla, Aniket, Andreas Halman, Sean William David Carter, Claire Moore, and Rachel K. Conyers. 2026. “Pharmacogenomic Determinants of Asparaginase‐Induced Hypersensitivity, Pancreatitis, Thrombosis, and Hepatotoxicity in Children: A Systematic Review.” Clinical Pharmacology & Therapeutics. https://doi.org/10.1002/cpt.70566.
Harvard
Chawla, A. et al. (2026) ‘Pharmacogenomic Determinants of Asparaginase‐Induced Hypersensitivity, Pancreatitis, Thrombosis, and Hepatotoxicity in Children: A Systematic Review’, Clinical Pharmacology & Therapeutics. doi:10.1002/cpt.70566.
IEEE
A. Chawla, A. Halman, S. W. D. Carter, C. Moore, and R. K. Conyers, “Pharmacogenomic Determinants of Asparaginase‐Induced Hypersensitivity, Pancreatitis, Thrombosis, and Hepatotoxicity in Children: A Systematic Review,” Clinical Pharmacology & Therapeutics, 2026, doi: 10.1002/cpt.70566.
BibTeX
@article{chawla2026pharmacogenomic,
title = {{Pharmacogenomic Determinants of Asparaginase‐Induced Hypersensitivity, Pancreatitis, Thrombosis, and Hepatotoxicity in Children: A Systematic Review}},
author = {Chawla, Aniket and Halman, Andreas and Carter, Sean William David and Moore, Claire and Conyers, Rachel K.},
journal = {Clinical Pharmacology \& Therapeutics},
year = {2026},
doi = {10.1002/cpt.70566},
url = {https://doi.org/10.1002/cpt.70566}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- L-asparaginase
- pharmacogenomics
- hypersensitivity
- pancreatitis
- thrombosis
- hepatotoxicity
- HLA class II alleles
- HLA-DRB1*0701
Work with this paper
Most-cited papers in Pharmacology, Toxicology and Pharmaceutics
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingOleg Trott, Arthur J. Olson · Journal of Computational Chemistry · 2009 · 39,860 citations
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibilityGarrett M. Morris, Ruth Huey, William Lindstrom and 4 more · Journal of Computational Chemistry · 2009 · 26,508 citations
- Development and testing of a general amber force fieldJunmei Wang, Romain M. Wolf, James W. Caldwell and 2 more · Journal of Computational Chemistry · 2004 · 20,080 citations
- Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1Christopher A. Lipinski, Franco Lombardo, Beryl W. Dominy and 1 more · Advanced Drug Delivery Reviews · 2001 · 19,638 citations
- SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small moleculesAntoine Daina, Olivier Alain Michielin, Vincent Zoete · Scientific Reports · 2017 · 19,557 citations
All highly cited Pharmacology, Toxicology and Pharmaceutics papers
Questions about this paper
How do I cite this paper in APA style?
Chawla, A., Halman, A., Carter, S. W. D., Moore, C., & Conyers, R. K. (2026). Pharmacogenomic Determinants of Asparaginase‐Induced Hypersensitivity, Pancreatitis, Thrombosis, and Hepatotoxicity in Children: A Systematic Review. Clinical Pharmacology & Therapeutics. https://doi.org/10.1002/cpt.70566
How many times has this paper been cited?
0 times, according to OpenAlex on 18 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at PubMed Central: sign in and open the full text from this page.
Who wrote this paper?
Aniket Chawla, Andreas Halman, Sean William David Carter, Claire Moore, Rachel K. Conyers.
What is the DOI of this paper?
10.1002/cpt.70566, permanently at https://doi.org/10.1002/cpt.70566. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 18 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.